SVP Zhou Ginger purchased 417 AZTA shares at $45.88; holdings now 27.9K shares. Company unprofitable, revenue flat YoY.
Zhou Ginger, SVP and General Manager of Genom division, purchased 417 shares of Azenta at $45.88 on 2025-01-31, bringing her post-transaction holdings to 27.9K shares—a modest 1.5% increase. The company is currently unprofitable (full-year net income was negative) with flat annual revenue growth (-1.3% YoY), and the stock is trading $51.97 versus a 52-week high of $67.30, representing a decline of 22.8% from that peak. The purchase occurred at a price below the current market level, though it remains within the historical trading range and represents a relatively small absolute transaction of $19.1K. This modest buy by a mid-level executive in a challenged operating environment does not constitute a material confidence signal; investors should monitor whether other insiders exhibit similar activity or whether company fundamentals show signs of stabilization.